VACCINATION WITH CONJUGATE PNEUMOCOCCAL VACCINE IN PREMATURE INFANTS AND CHILDREN WITH CONGENITAL HEART DEFECTS
Keywords:
Children, premature babies, pneumococcal vaccine, congenital heart diseaseAbstract
193 vaccinated children were observed for 1.5 years. At the age of 2–6 months, 30% of premature and 46% of children with congenital heart defects were vaccinated with the PCV7/PCV13 vaccine; at the age of 7–11 months, 52 and 40%, respectively. In 65% of cases, the PCV7/PCV13 vaccine was administered together with other vaccines in the national preventive vaccination schedule. The frequency of general post-vaccination reactions (increase in body temperature from 37.6 to 38.0°C) was 4%; no local reactions were recorded. No other adverse events were noted in the post-vaccination period.
References
Savilov E.D., Ilyina S.V., Briko N.I. Manifestations of infectious morbidity in conditions of environmental distress. Epidemiology and infectious diseases. 2019; 5:34–38.
Savilov E.D., Ilyina S.V. Infectious pathology in conditions of technogenic environmental pollution: clinical and epidemiological studies. Novosibirsk: Science. 2010. 248 p.
Ilyina S.V., Kiklevich V.T., Savilov E.D. Immune response to acute respiratory infections in children occurring against the background of technogenic environmental pollution. Sib. honey. magazine. 2011; 26 (51): 63–67.
Baranov A.A., Shcheplyagina L.A. Children's health on the threshold of the 21st century: ways to solve the problem. Rus. honey. magazine. 2020; 8 (18): 3–8.
